Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00727623Completed

Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium

Role: collaborator

NCT01516099Phase 4Completed

A Structural Approach to Implement the Role of 'Physical Activity Counselors' in Sports and Exercise Promotion

Role: collaborator

NCT00107601Not ApplicableCompleted

Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients

Role: collaborator

NCT00409461Not ApplicableTerminated

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Role: collaborator

All 4 trials loaded